OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	64
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	45
Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma	39
Optimal management of oligometastatic prostate cancer: current state and future directions	36
Treatments and challenges in advanced prostate cancer	34
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	31
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	29
Role of PSMA PET/CT in imaging and management of prostate cancer	28
Editorial introductions	27
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	26
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	25
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	23
Psycho-oncology interventions focusing on fatigue and sleep disturbances	23
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	20
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	20
Editorial introductions	19
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	19
Editorial introductions	18
Safety of assisted reproductive techniques in gynecological cancer patients	17
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	16
New hopes in relapsed refractory primary central nervous system lymphoma	15
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	15
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	14
How to prevent human papillomavirus-related oropharyngeal cancer?	14
Indications and technique of minimally invasive surgery in early-stage cervical cancer	13

Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	13
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	13
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	13
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	13
Editorial introductions	13
Open questions on vorasidenib	13
Biomarkers and immunotherapy: where are we?	13
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	12
The evolving landscape of bispecific antibodies in the treatment of lung cancer	12
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	12
Editorial introductions	12
Circulating tumor DNA in breast cancer: a biomarker for patient selection	12
Recent highlights and breakthroughs in immunotherapy for head and neck cancers	12
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	12
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	12
Liquid biopsy in brain tumors: moving on, slowly	11
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
Recent advances in precision medicine for acute myeloid leukemia	11
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	11
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	11
Pathology and new insights in central nervous system lymphomas	10
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	10
Lung cancer screening in never smokers	10
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	10
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	10
Editorial introductions	10
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	10
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	9
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	9
Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings	9
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	9
Artificial intelligence in lung cancer: from diagnosis to therapy	9
A new comprehensive and stratified concept for supportive care in cancer patients	9
Editorial introductions	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	8
The 5T's of health disparities in multiple myeloma in Latin America	8
Current role and indications of minimally invasive surgery in gynecologic oncology	8
How to support parenting in patients with cancer and co-parents? From research to practice	8
Machine learning applications and challenges in graft-versus-host disease: a scoping review	8
Application of single-port techniques in endometrial cancer	8
Mind the target: programmed death ligand 1 in oesophagogastric cancers	8
Melanoma in adolescents and young adults: special considerations	8
Desmoid tumors: who, when and how to treat?	8
Editorial introductions	8
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	8
Targeting cancer stem cell pathways for lung cancer therapy	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Potential application of artificial intelligence in cancer therapy	7
Pathologic diagnosis of lung cancer – recent developments	7
Adjuvant and neoadjuvant approaches in pancreatic cancer	7

Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	7
New therapies for brain metastases: an update	7
Editorial introductions	7
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	7
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	7
Preclinical glioma models in neuro-oncology: enhancing translational research	7
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	7
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	7
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	7
Breast surgery after neoadjuvant therapy	7
Evolving paradigms in the management of basal cell carcinoma	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer	7
Treatment of radiation-associated angiosarcoma	7
Global priorities for advancing cancer survivorship	7
Patient-proxy agreement on health-related quality of life assessment in cancer patients	6
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	6
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	6
Precision, personalization, and quality of life for patients with lymphoma	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
Achievements of international rare cancers networks and consortia in the neuro-oncology field	6
HIV-related lymphomas	6
Polyamine metabolism in prostate cancer	6
Clinical management of brain tumors in pregnancy	6
Editorial introductions	6
Cellular therapies in sarcoma and other solid tumors	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	6
Richter transformation: biological insights, diagnostic challenges and emerging therapies	6
Unclear territory: navigating metastatic nonclear cell renal cell carcinoma	6
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	6
Question prompt lists to improve communication between cancer patients and healthcare professionals	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
How to treat localized Hodgkin lymphoma?	6